ContractExclusive Sub-License Agreement • June 27th, 2013 • Iroko Pharmaceuticals Inc. • Pharmaceutical preparations • England and Wales
[***] indicates material that has been omitted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission. A complete copy of this agreement, including redacted portions so indicated, has been filed separately with the Securities and Exchange Commission.
Re: Amendment to Exclusive Sub-License Agreement (“Agreement”) between Progenics Pharmaceuticals, Inc. (“Licensee”) and UR Labs, Inc. (“Licensor”) dated September 21, 2001Exclusive Sub-License Agreement • September 20th, 2004 • Progenics Pharmaceuticals Inc • Pharmaceutical preparations
RECITALS:Exclusive Sub-License Agreement • September 29th, 2003 • Applied Dna Sciences Inc • Services-computer processing & data preparation
Exclusive Sub-license Agreement between (Sub-licensor) and 9Webzen (Shanghai) Co., Ltd. (Sub-licensee) for Network Game MU Software January 29, 2003Exclusive Sub-License Agreement • November 26th, 2004 • The9 LTD
This Exclusive Sub-license Agreement for Software (hereinafter this “Agreement”) is entered into in Shanghai of the People’s Republic of China (hereinafter “PRC”) as of January 29, 2003 by and between the following two Parties:
Beijing Bio-Bridge Science Corporation Exclusive Sub-License Agreement Bio- Bridge Science Corporation Page 1 of 3 ---------------------------------------- ---------------------------------------- EXCLUSIVE SUB-LICENSE AGREEMENT WHEREAS Liang Qiao and...Exclusive Sub-License Agreement • December 30th, 2004 • Bio Bridge Science Inc
